dr.s.r.muthuramalingam consultant medical oncologist portsmouth...
TRANSCRIPT
![Page 1: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/1.jpg)
ESMO Preceptorship Programme
Locally advanced BRAF mutant positive
colon cancer
Dr.S.R.Muthuramalingam
Consultant Medical Oncologist
Portsmouth Oncology Centre
Queen Alexandra Hospital
United Kingdom
Locally advanced– Right side – 25/11/16
![Page 2: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/2.jpg)
ESMO PRECEPTORSHIP PROGRAM
Case Presentation
� 38-yr old lady with with two young children aged 11 and 8
� Past medical history: Low BP, Transient collapse due to atrial flutter, low platelet counts during pregnancies
� Admitted in the hospital with fever and diarrhoeafollowing holiday in the Dominican Republic
� Readmission after a few months with fever, diarrhoea, backache and lump in the right abdomen
� Two stones of weight loss
� Clinically palpable lump in the right abdomen
![Page 3: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/3.jpg)
ESMO PRECEPTORSHIP PROGRAM
Investigations
� CT scan: 6x5 cm mass in the hepatic flexure invading retroperitoneal space and extending to third part of duodenum with a 15 mm defect in the anterior wall of duodenum; enlarged local regional nodes.
� PET scan: SUV 15.4 hepatic flexure tumourextending to the duodenum with no distant metastases
� Colonoscopy and biopsy: Adenocarcinoma RAS wild type; BRAF (V600) and TP53 mutation positive
![Page 4: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/4.jpg)
![Page 5: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/5.jpg)
![Page 6: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/6.jpg)
![Page 7: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/7.jpg)
ESMO PRECEPTORSHIP PROGRAM
Treatment
� Discussed in the colorectal and hepatobiliary MDTs
� FOLFOX plus panitumumab – 6 cycles
� Post treatment CT: Significant reduction in the size of the hepatic flexure tumour from 53 to 28 mm but still remained adherent to the duodenum
� MRI of abdomen: No pancreatic involvement but distal part of the duodenum involved with the tumour
� Right hemicolectomy with enbloc wedge resection of duodenum
� Histology: T4 N1 Adenocarcinoma with 1 out 3 nodes positive
� 6 cycles of adjuvant FOLFOX chemotherapy
![Page 8: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/8.jpg)
![Page 9: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/9.jpg)
![Page 10: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/10.jpg)
![Page 11: Dr.S.R.Muthuramalingam Consultant Medical Oncologist Portsmouth ...oncologypro.esmo.org/content/download/99326/1747813/...Barcelona... · Dr.S.R.Muthuramalingam Consultant Medical](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5b8716527f8b9a2d238bf5d9/html5/thumbnails/11.jpg)
ESMO PRECEPTORSHIP PROGRAM
Post treatment
� Post treatment CT: No evidence of recurrence
� She has been referred to the regional genetic department
� She will be followed up in the colorectal follow-up programme